Original articleA comparison of doxorubicin, epirubicin and mitozantrone as single agents in advanced breast carcinoma
References (3)
- et al.
A randomised, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer
Eur J Cancer Clin Oncol
(1987)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1993 Published by Elsevier Ltd.